CD4 and cholangiocarcinoma: In a widely cited paper from 2014, Tran et al. saw disease stabilization in a patient who was treated with TILs (CD4+ T helper 1 cells) that recognized mutated erbb2 interacting protein (ERBB2IP) expressed by metastatic CCA cells [72].